Ledasorexton clinical trials
How each study uses ledasorexton is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ledasorexton studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- E2086
- 6
Studies by the year they started
6 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test ledasorexton.
- Nov 2026A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy ParticipantsPhase 1 · Eisai Inc.
- Feb 2027A Study to Evaluate the Efficacy and Safety of E2086 in Adults With NarcolepsyPhase 2 · Eisai Inc.
Studies
Open first, then newest update. How each study uses ledasorexton is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy ParticipantsRecruitingPhase 1Eisai Inc.NCT07766369Written as E2086
- A Study to Evaluate the Efficacy and Safety of E2086 in Adults With NarcolepsyRecruitingPhase 2Eisai Inc.NCT07493265Written as E2086
- A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male ParticipantsCompletedPhase 1Eisai Inc.NCT07308236Written as E2086
- A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1CompletedPhase 1Eisai Inc.NCT06462404Written as E2086
- A Study of E2086 in Healthy Adult ParticipantsCompletedPhase 1Eisai Inc.NCT06481488Written as E2086
- A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly ParticipantsCompletedPhase 1Eisai Inc.NCT05745207Written as E2086
Codes
What other systems call ledasorexton · ClinicalTrials.gg INT018590
- UNII (FDA) YF7U7E62ELLEDASOREXTONConfirmed FDA, Wikidata
- Wikidata Q140288896ledasorextonConfirmed FDA, Wikidata
- NCI Thesaurus C224754LedasorextonOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | YF7U7E62EL | LEDASOREXTON | Confirmed FDA, Wikidata |
| Wikidata | Q140288896 | ledasorexton | Confirmed FDA, Wikidata |
| NCI Thesaurus | C224754 | Ledasorexton | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.